Results 171 to 180 of about 39,211 (299)
Editorial: Pharmacogenetics and pharmacogenomics in psychiatry: challenges and opportunities. [PDF]
Samardzic J, Allegaert K, Karamperis K.
europepmc +1 more source
Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications
Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba +2 more
wiley +1 more source
The Impact of Incorporating of Pharmacogenomics into the Pharmacy Curriculum on Student Interest
Background: Pharmacogenomics content in the pharmacy curriculum has increased since AACP adopted NCHPEG guidelines in 2001. Aims: To evaluate how program level curricular changes impact pharmacy student opinions regarding pharmacogenomics, and gauge ...
Hakobyan, Leann +4 more
core
The Clinical Pharmacogenetics Implementation Consortium (CPIC) TPMT/NUDT15 Pharmacogene Curation Expert Panel (PCEP) conducted a comprehensive review of clinical, laboratory, and computational evidence to determine the clinical function assignments for TPMT and NUDT15 star alleles.
Bailey M. Tibben +10 more
wiley +1 more source
Science of omics: a molecular space odyssey
Experimental Physiology, EarlyView.
Salomé Coppens +3 more
wiley +1 more source
Genetic variation influences the pharmacological response to metformin and SGLT2 inhibitors in patients with type 2 diabetes mellitus. Pharmacogenetic biomarkers affecting drug transport, metabolism and target activity contribute to inter‐individual differences in treatment efficacy and adverse effects, supporting the implementation of personalized ...
Imran Hossain +6 more
wiley +1 more source
We synthesized four novel carprofen‐derived carbazole–acylthiourea propanamides with selective antimicrobial activity against Staphylococcus aureus, Enterococcus faecalis, and Candida albicans. Compound 1a provides combined antioxidant and antihemolytic protection.
Carmen Limban +17 more
wiley +1 more source
Integrating Artificial Intelligence with Emerging Pharmaceutical Technologies: Current Progress, Clinical Translation, and Future Challenges. [PDF]
Sharma P +3 more
europepmc +1 more source
Garlic bioactive compounds, including organosulfur compounds (allicin, DADS, DATS, and SAC), phenolic compounds, and quercetin, regulate the Nrf2/HO‐1, NF‐κB, PI3K/Akt, and AMPK/eNOS signaling pathways. These actions enhance antioxidant defenses, suppress inflammation, improve metabolic and cardiovascular function, and contribute to reduced blood ...
Gudisa Bereda
wiley +1 more source
Targeting Problems and Adhering to Standards: A Pathway to Uniform Clinical Laboratory Processes that Maximize the Benefits of Pharmacogenomics. [PDF]
Fieg E +6 more
europepmc +1 more source

